Quarterly report pursuant to Section 13 or 15(d)

Revenue and Accounts Receivable (Tables)

v3.7.0.1
Revenue and Accounts Receivable (Tables)
6 Months Ended
Jun. 30, 2017
Receivables [Abstract]  
Schedule of revenue by service type
Revenue by service type for the three and six months ended June 30, 2017 and 2016 is comprised of the following (in thousands): 

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
 
2016
 
2017
 
2016
Biopharma Services
$
3,288

 
$
4,219

 
7,007

 
$
7,569

Clinical Services
3,053

 
2,542

 
6,007

 
4,998

Discovery Services
263

 
240

 
556

 
502

 
$
6,604

 
$
7,001

 
$
13,570

 
$
13,069

Schedule of accounts receivable by service type
Accounts receivable by service type at June 30, 2017 and December 31, 2016 consists of the following (in thousands): 


June 30,
2017
 
December 31,
2016
Biopharma Services
$
2,588

 
$
3,683

Clinical Services
11,783

 
8,972

Discovery Services
407

 
480

Allowance for doubtful accounts
(1,623
)
 
(1,387
)

$
13,155

 
$
11,748



Allowance for Doubtful Accounts (in thousands)
Balance, December 31, 2016
$
1,387

Bad debt expense
236

Balance, June 30, 2017
$
1,623

Schedule of clinical services revenue (as a percent of total revenue)
The breakdown of our Clinical Services revenue (as a percent of total revenue) is as follows:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2017
 
2016
 
2017
 
2016
Medicare
16%
 
12%
 
15%
 
13%
Other insurers
24%
 
17%
 
23%
 
19%
Other healthcare facilities
6%
 
7%
 
6%
 
6%
 
46%
 
36%
 
44%
 
38%